An Immersive Virtual Reality Curriculum for Pediatric Hematology Clinicians on Shared Decision-making for Hydroxyurea in Sickle Cell Anemia.
An Immersive Virtual Reality Curriculum for Pediatric Hematology Clinicians on Shared Decision-making for Hydroxyurea in Sickle Cell Anemia.
复制标题
DOI：
10.1097/mph.0000000000002289
复制
发表时间：
2022-04-01
期刊：
影响因子：
--
通讯作者：
Crosby LE
中科院分区：
文献类型：
--
作者：
Real FJ;Hood AM;Davis D;Cruse B;Klein M;Johnson Y;McTate E;Brinkman WB;Hackworth R;Hackworth K;Quinn CT;Crosby LE
尽管羟基脲（HU）是治疗镰状细胞性贫血的有效药物，但摄取量仍然很低。共享决策（SDM）是一个建议的战略，胡启动，以引起家庭的喜好，但是，临床医生缺乏SDM的培训。我们在八个儿科机构实施了沉浸式虚拟现实（VR）课程，以培训临床医生SDM，包括咨询虚拟患者。在VR模拟后，临床医生对所有评估的沟通技能的自我报告信心显著提高，包括提出开放式问题、引出特定问题和确认理解（所有人的ps ≤ 0.01）。VR可能是一种有效的方法，教育临床医生从事SDM为HU。
Although hydroxyurea (HU) is an effective treatment for sickle cell anemia, uptake remains low. Shared decision making (SDM) is a recommended strategy for HU initiation to elicit family preferences; however, clinicians lack SDM training. We implemented an immersive virtual reality (VR) curriculum at eight pediatric institutions to train clinicians on SDM that included counseling virtual patients. Clinicians’ self-reported confidence significantly improved following the VR simulations on all communication skills assessed, including asking open-ended questions, eliciting specific concerns, and confirming understanding (ps ≤ 0.01 for all). VR may be an effective method for educating clinicians to engage in SDM for HU.